Metabolic targets for cancer therapy

Nature Reviews Drug Discovery 12, 829–846 (2013) There were some inaccuracies in the following sentence on p839 of the article: “Along similar lines, the pharmacological or genetic inhibition of phosphoglycerate mutase 1 (PGAM1) reduces tumour growth in vitro and in vivo, perhaps owing (at least in part) to the G6PD-inhibitory effects of 3-phosphoglycerate222.